Marcelo Maia Pinheiro

7PUBLICATIONS
25CO-AUTHORS
Pharmaceutical delivery technologiesAutoimmunityCancer diagnosisFood properties (incl. characteristics and health benefits)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 22, 2025
Combined Use of Vitamin D and DPP-4 Inhibitors as a Potential Adjuvant Treatment Strategy to Enhance the Efficacy of Novel Beta-Cell Replacement Therapies for Type 1 Diabetes.

Marcelo Maia Pinheiro, Felipe Moura Maia Pinheiro, Bruna Fioravante Di Serio

|Feb 26, 2025
Unveiling the Therapeutic Potential of the Second-Generation Incretin Analogs Semaglutide and Tirzepatide in Type 1 Diabetes and Latent Autoimmune Diabetes in Adults.

Marco Infante, Francesca Silvestri, Nathalia Padilla

|Feb 26, 2024
PRE1BRAZIL Protocol: A Randomized Controlled Trial to Evaluate the Effectiveness and Safety of the DPP-4 Inhibitor Alogliptin in Delaying the Progression of Stage 2 Type 1 Diabetes.

Jaquellyne Gurgel Penaforte-Saboia, Carlos Eduardo Barra Couri, Natasha Vasconcelos Albuquerque

|Nov 13, 2023
Type 1 diabetes prevention and treatment: Time to think outside the box.

Marcelo Maia Pinheiro, Felipe Moura Maia Pinheiro

|Oct 27, 2023
Comment on Russell et al. Abatacept for Delay of Type 1 Diabetes Progression in Stage 1 Relatives at Risk: A Randomized, Double-Masked, Controlled Trial. Diabetes Care 2023;46:1005-1013.

Marcelo Maia Pinheiro, Felipe Moura Maia Pinheiro

|Apr 28, 2021
Cytokine storm modulation in COVID-19: a proposed role for vitamin D and DPP-4 inhibitor combination therapy (VIDPP-4i).

Marcelo Maia Pinheiro, Andrea Fabbri, Marco Infante

Pageof 2

Frequent Collaborators

3 joint publications

Marco Infante

2 joint publications

Andrea Fabbri

2 joint publications

Nathalia Padilla

1 joint publications

Louise T Bendahan